Real-world Experience with Favipiravir for Treatment of COVID-19 in Thailand: Results from a Multicenter Observational Study

Pinyo Rattanaumpawan, Supunnee Jirajariyavej, Kanokorn Lerdlamyong, Nattawan Palavutitotai, Jatuporn Saiyarin
doi: https://doi.org/10.1101/2020.06.24.20133249

Article Information

doi 
https://doi.org/10.1101/2020.06.24.20133249
History 
  • July 1, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Pinyo Rattanaumpawan1,*,
  2. Supunnee Jirajariyavej2,
  3. Kanokorn Lerdlamyong3,
  4. Nattawan Palavutitotai4 and
  5. Jatuporn Saiyarin5
  1. 1Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
  2. 2Internal Medicine Unit, Taksin Hospital, Bangkok, Thailand
  3. 3Internal Medicine Unit, Vachira Phuket Hospital, Phuket, Thailand
  4. 4Internal Medicine Unit, Lerdsin Hospital, Bangkok, Thailand
  5. 5Internal Medicine Unit, Central Hospital, Bangkok, Thailand
  1. ↵*Correspondence to:
    Pinyo Rattanaumpawan, MD, MSCE, PhD, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Thailand, Tel: (+66) 2-419-7784; Fax: (+66) 2-419-7783, E-mail: pinyo.rat{at}mahidol.ac.th
Back to top
Posted July 01, 2020.
Download PDF
Data/Code
Email
Real-world Experience with Favipiravir for Treatment of COVID-19 in Thailand: Results from a Multicenter Observational Study
Pinyo Rattanaumpawan, Supunnee Jirajariyavej, Kanokorn Lerdlamyong, Nattawan Palavutitotai, Jatuporn Saiyarin
medRxiv 2020.06.24.20133249; doi: https://doi.org/10.1101/2020.06.24.20133249
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area